Office of Biotechnology Activities    National Institutes of Health - Office of Science Policy   Frequently Asked Questions and Other Guidance   Frequently Asked Questions are available for the following subject areas:     NIH Review Process for Human Gene Transfer Trials     Vaccine Exemption in the NIH Guidelines for Research Involving Recombinant DNA Molecules     Major Actions under Section III-A of the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (revised March 5, 2013)     NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (April 2013)     Experiments that are Exempt from the NIH Guidelines(April 2013)     Genetically Modified (Transgenic) Animals and the Use of Recombinant or Synthetic Nucleic Acid Molecules in Animals     Frequently Asked Questions on IBCs (April 2013)     Frequently Asked Questions on IBC-RMS (April 2013)     Frequently Asked Questions on Externally Administered IBCs (April 2013)     Frequently Asked Questions on IBC Meetings and Minutes (April 2013)     Incident Reporting (revised May 22, 2013)

6705 Rockledge Drive, Suite 750, MSC 7985 Bethesda, MD 20892-7985 (For all non-USPS mail, please use ZIP code 20817) Phone: 301-496-9838, Fax: 301-496-9839 E-mail OBA at oba@od.nih.gov

RDNA005